Complicated otitis media and its implications

Eugene Leibovitz1

  • 1Pediatric Infectious Disease Unit, Soroka University Medical Center, Ben-Gurion University of the Negev, Beer-Sheva, Israel. eugenel@bgu.ac.il

Vaccine
|December 20, 2008
PubMed

Insights

Recurrent otitis media (OM) is often caused by new infections, not relapses, emphasizing the need for bacterial eradication. The pneumococcal conjugate vaccine (PCV7) may help prevent OM complications like mastoiditis.

Area of Science:

  • Pediatric infectious diseases
  • Otolaryngology
  • Vaccinology

Background:

  • Complicated otitis media (OM), including persistent and recurrent acute otitis media (AOM), is a significant pediatric health issue.
  • Microbiological studies indicate that most recurrent AOM episodes within a month of antibiotic treatment are new infections, not relapses.

Purpose of the Study:

  • To highlight the importance of bacteriological eradication for preventing recurrent acute otitis media (R-AOM).
  • To present data on the impact of the seven-valent pneumococcal conjugate vaccine (PCV7) on AOM complications, specifically mastoiditis.

Main Methods:

  • Review of double-tympanocentesis studies comparing microbiology of initial and recurrent AOM episodes.
  • Analysis of data concerning the effects of PCV7 on AOM complications.

Main Results:

  • Most recurrent AOM episodes within one month post-antibiotic therapy are identified as new infections.
  • The seven-valent pneumococcal conjugate vaccine (PCV7) targets key AOM pathogens like Streptococcus pneumoniae.

Conclusions:

  • Bacteriological eradication is crucial for preventing subsequent R-AOM episodes.
  • PCV7 shows potential in reducing AOM complications, including mastoiditis.

Related Concept Videos

Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.